Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Pathology Department, Hospital Universitario La Paz, Madrid, Spain.
ESMO Open. 2022 Oct;7(5):100568. doi: 10.1016/j.esmoop.2022.100568. Epub 2022 Aug 22.
Tumor spread through air spaces (STAS) in lung adenocarcinoma is a novel mechanism of invasion. STAS has been proposed as an independent predictor of poor prognosis. The aim of this study was to evaluate the correlations between STAS status and other clinicopathologic variables and to assess the prognostic implications of STAS and the distance from the edge of the tumor to the farthest STAS in patients with resected lung adenocarcinoma.
This is a single-institution retrospective observational study. We included all patients with resected lung adenocarcinoma from January 2017 to December 2018 at La Paz University Hospital. The cut-off for the distance from the edge of the tumor to the farthest STAS was 1.5 mm and was assessed by the area under the receiver operating characteristic curve.
A total of 73 patients were included. STAS was found in 52 patients (71.2%). Histological grade 3 (P = 0.035) and absence of lepidic pattern (P = 0.022) were independently associated with the presence of STAS. The median recurrence-free survival (RFS) was 48.06 months [95% confidence interval (CI) 33.58 months to not reached]. STAS-positive patients had shorter median RFS [39.23 months (95% CI 29.34-49.12 months)] than STAS-negative patients (not reached) (P = 0.04). STAS-positive patients with a distance from the edge of the tumor to the farthest STAS ≥1.5 mm had an even shorter median RFS [37.63 months (95% CI 28.14-47.11 months)]. For every 1 mm increase in distance, the risk of mortality increased by 1.26 times (P = 0.04).
Histological grade 3 and absence of lepidic pattern were independently associated with the presence of STAS. STAS was associated with a higher risk of recurrence. The distance from the edge of the tumor to the farthest STAS also had an impact on overall survival.
肺腺癌中的肿瘤通过气腔播散(STAS)是一种新的侵袭机制。STAS 已被提议作为预后不良的独立预测因子。本研究的目的是评估 STAS 状态与其他临床病理变量之间的相关性,并评估 STAS 状态和肿瘤边缘到最远 STAS 之间的距离对接受肺腺癌切除的患者的预后意义。
这是一项单机构回顾性观察研究。我们纳入了 2017 年 1 月至 2018 年 12 月在拉帕兹大学医院接受肺腺癌切除术的所有患者。肿瘤边缘到最远 STAS 的距离的截断值为 1.5 毫米,并通过接受者操作特征曲线下的面积进行评估。
共纳入 73 例患者。52 例(71.2%)患者存在 STAS。组织学 3 级(P=0.035)和缺乏贴壁样模式(P=0.022)与 STAS 的存在独立相关。无复发生存期(RFS)的中位数为 48.06 个月[95%置信区间(CI)33.58 个月至未达到]。STAS 阳性患者的中位 RFS 更短[39.23 个月(95%CI 29.34-49.12 个月)],低于 STAS 阴性患者(未达到)(P=0.04)。肿瘤边缘到最远 STAS 的距离≥1.5 毫米的 STAS 阳性患者的中位 RFS 更短[37.63 个月(95%CI 28.14-47.11 个月)]。距离每增加 1 毫米,死亡风险增加 1.26 倍(P=0.04)。
组织学 3 级和缺乏贴壁样模式与 STAS 的存在独立相关。STAS 与更高的复发风险相关。肿瘤边缘到最远 STAS 的距离也对总生存有影响。